|
82
|
285
|
4r1yA |
Identification and optimization of pyridazinones as potent and selective c-met kinase inhibitor |
|
79
|
271
|
4qygA |
Chk1 kinase domain in complex with diazacarbazole compound 14 |
|
79
|
295
|
4rj3A |
Cdk2 with egfr inhibitor compound 8 |
|
97
|
289
|
4qmvA |
Mst3 in complex with pf-03814735, n-{2-[(1s,4r)-6-{[4-(cyclobutylamino)-5-(trifluoromethyl)pyrimidin-2-yl]amino}-1,2,3,4-tetrahydro-1,4-epiminonaphthalen-9-yl]-2-oxoethyl}acetamide |
|
100
|
287
|
4qmzA |
Mst3 in complex with sunitinib |
|
87
|
289
|
4qt1A |
Jak3 kinase domain in complex with 1-[(3s)-1-isobutylsulfonyl-3-piperidyl]-3-(5h-pyrrolo[2,3-b]pyrazin-2-yl)urea |
|
122
|
351
|
4qtbA |
Structure of human erk1 in complex with sch772984 revealing a novel inhibitor-induced binding pocket |
|
82
|
263
|
4rfmA |
Itk kinase domain in complex with compound 1 n-{1-[(1,1-dioxo-1-thian-2-yl)(phenyl)methyl]-1h- pyrazol-4-yl}-5,5-difluoro-5a-methyl-1h,4h,4ah,5h,5ah,6h-cyclopropa[f]indazole-3-carboxamide |
|
91
|
346
|
4qpaA |
Crystal structure of erk2 in complex with 7-(1-benzyl-1h-pyrazol-4-yl)-2-(pyridin-4-yl)-5h-pyrrolo[2,3-b]pyrazine |
|
75
|
273
|
4rblA |
Crystal structure of ser/thr kinase pim1 in complex with mitoxantrone derivatives |
|
102
|
349
|
4qp2A |
Crystal structure of erks in complex with 5-chlorobenzo[d]oxazol-2-amine |
|
86
|
323
|
4r3rA |
Crystal structures of egfr in complex with mig6 |
|
80
|
273
|
4rpvA |
Co-crystal structure of pim1 with compound 3 |
|
86
|
323
|
4r3pA |
Crystal structures of egfr in complex with mig6 |
|
114
|
327
|
4rlkA |
Crystal structure of z. mays ck2alpha in complex with the atp-competitive inhibitor 4-[(e)-(fluoren-9-ylidenehydrazinylidene)-methyl] benzoate |
|
93
|
281
|
4qo9A |
Mst3 in complex with danusertib |
|
92
|
322
|
4rj7A |
Egfr kinase (t790m/l858r) with inhibitor compound 1 |
|
99
|
289
|
4qmmA |
Mst3 in complex with at-9283, 4-[(2-{4-[(cyclopropylcarbamoyl)amino]-1h-pyrazol-3-yl}-1h-benzimidazol-6-yl)methyl]morpholin-4-ium |
|
90
|
285
|
4qnaA |
Mst3 in complex with 2-(4,6-diamino-1,3,5-triazin-2-yl)phenol |
|
87
|
286
|
4rqkA |
Crystal structure of pdk1 in complex with atp and the pif-pocket ligand rs1 |
|
105
|
346
|
4qp8A |
Crystal structure of erk2 in complex with 2-(1h-pyrazol-4-yl)-7-(pyridin-3-yl)-5h-pyrrolo[2,3-b]pyrazine |
|
95
|
291
|
4r1vA |
Identification and optimization of pyridazinones as potent and selective c-met kinase inhibitors |
|
90
|
285
|
4rioA |
Crystal structure of jak3 kinase domain in complex with a pyrrolopyridazine carboxamide inhibitor |
|
77
|
304
|
4pdpA |
Crystal structure of rad53 kinase domain and scd2 |
|
75
|
265
|
4qd6A |
Itk kinase domain in complex with inhibitor compound |
|
87
|
275
|
4pv0A |
Crystal structure of spleen tyrosine kinase (syk) in complex with an imidazopyrazine inhibitor |
|
84
|
295
|
4p5zA |
Human epha3 kinase domain in complex with quinoxaline derivatives |
|
159
|
599
|
4oliA |
The pseudokinase/kinase protein from jak-family member tyk2 |
|
103
|
347
|
4pteA |
Structure of a carvoxamide compound (15) (n-[4-(isoquinolin-7-yl)pyridin-2-yl]cyclopropanecarboxamide) to gsk3b |
|
76
|
264
|
4pp9A |
Itk kinase domain with compound 1 (n-[1-(3-cyanobenzyl)-1h-pyrazol-4-yl]-2h-indazole-3-carboxamide) |
|
84
|
293
|
4p90A |
Crystal structure of the kinase domain of human pak1 in complex with compound 15 |
|
90
|
296
|
4p5qA |
Human epha3 kinase domain in complex with quinoxaline derivatives |
|
82
|
286
|
4pdoA |
Structure of ephrin type-a receptor 2 |
|
79
|
273
|
4q9sA |
Crystal structure of human focal adhesion kinase (fak) bound to compound1 (3,5-dihydro[1,2,4]triazino[3,4-c][1,4]benzoxazin-2(1h)-one) |
|
88
|
273
|
4px6A |
Syk catalytic domain in complex with a potent pyridopyrimidinone inhibitor |
|
90
|
291
|
4pmsA |
The structure of trka kinase bound to the inhibitor 4-naphthalen-1-yl-1-[(5-phenyl-1,2,4-oxadiazol-3-yl)methyl]-1h-pyrrolo[3,2-c]pyridine-2-carboxylic acid |
|
107
|
403
|
4pl5A |
Crystal structure of murine ire1 in complex with oicr573 inhibitor |
|
85
|
292
|
4p4cA |
Human epha3 kinase domain in complex with quinoxaline derivatives |
|
66
|
271
|
4q2aA |
Wnk1: a chloride sensor via autophosphorylation |
|
66
|
264
|
4ppcA |
Itk kinase domain with compound 27 (n-{1-[(1r)-3-(dimethylamino)-1-phenylpropyl]-1h-pyrazol-4-yl}-6-(1h-pyrazol-4-yl)-1h-indazole-3-carboxamide) |
|
93
|
405
|
4pl3A |
Crystal structure of murine ire1 in complex with mkc9989 inhibitor |
|
81
|
277
|
4p2kA |
Structure of ephrin type-a receptor 2 |
|
78
|
281
|
4otwA |
Her3 pseudokinase domain bound to bosutinib |
|
83
|
271
|
4puzA |
Crystal structure of spleen tyrosine kinase (syk) in complex with gs-9973 |
|
84
|
259
|
4pqnA |
Itk kinase domain with compound gne-9822 |
|
110
|
402
|
4pl4A |
Crystal structure of murine ire1 in complex with oicr464 inhibitor |
|
69
|
300
|
4pdsA |
Crystal structure of rad53 kinase domain and scd2 in complex with amppnp |
|
93
|
290
|
4py1A |
Crystal structure of tyk2 in complex with compound 15, 6-((2,5-dimethoxyphenyl)thio)-3-(1-methyl-1h-pyrazol-4-yl)-[1,2,4]triazolo[4,3-b]pyridazine |
|
89
|
346
|
4ptcA |
Structure of a carboxamide compound (3) (2-{2-[(cyclopropylcarbonyl)amino]pyridin-4-yl}-4-oxo-4h-1lambda~4~,3-thiazole-5-carboxamide) to gsk3b |
|
85
|
291
|
4pmtA |
The structure of trka kinase bound to the inhibitor n~4~-(4-morpholin-4-ylphenyl)-n~6~-(pyridin-3-ylmethyl)pyrido[3,2-d]pyrimidine-4,6-diamine |
